A Partnership Between AACC & Life Dx.
The regions leaders in laboratory management including, laboratory professionals from GCC countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Jordan, Egypt, Turkey and the entire African continent will be invited to participate.
Why Delegates Attend AACC Middle East
- IMARC Group expects the UAE In-Vitro diagnostics (IVD) devices market to grow at a CAGR of around 9% during 2021-2026.
- In the Gulf Cooperation Council (GCC) region, the healthcare sector has witnessed phenomenal growth over the past decade, evidenced by an increased supply of healthcare establishments. Overall, healthcare-related expenditure in the Gulf is expected to grow to USD 89 billion by 2022, representing an overall increase of nearly 50% from 2013 to 2022.
- From 2018 to 2022, private-sector healthcare spending in the UAE is forecast to grow at 9.5% CAGR
- In the UAE, the number of hospitals increased substantially from 107 in 2013 to over 140 in 2019. As of 2019, this comprised a total of approximately 14,000 hospital beds.
- The privatization of hospitals and mandatory medical insurance, especially in Dubai and Abu Dhabi, will likely encourage spending and contribute to a more integrated health system.
The global IVD market is expected to increase from $60.3 billion to $81.1 billion by 2020 at a CAGR of 6.1%.
Market share in developed regions is projected to fall from 65% to 54% as markets mature in the Middle East and Africa.
The GCC is likely to become the fastest growing IVD market as investments in healthcare increase from the government and private sector.
Contributing factors include a rising number of expatriates, growing demand for health insurance, and increasing incidences of lifestyle diseases as the populations has access to disposable income.
Intense research and a surge in the demand for IVD tests for chronic health conditions are fueling growth in the region. Also, a high demand for technologically advanced devices for early and precise detection of diseases is needed to combat the rapid rise of chronic and infectious diseases.